Sergey Yurasov

2023

In 2023, Sergey Yurasov earned a total compensation of $1.2M as Chief Medical Officer at Black Diamond Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$205,065
Option Awards$514,760
Salary$488,250
Other$25,609
Total$1,233,684

Yurasov received $514.8K in option awards, accounting for 42% of the total pay in 2023.

Yurasov also received $205.1K in non-equity incentive plan, $488.3K in salary and $25.6K in other compensation.

Rankings

In 2023, Sergey Yurasov's compensation ranked 962nd out of 2,821 executives tracked by ExecPay. In other words, Yurasov earned more than 65.9% of executives.

ClassificationRankingPercentile
All
962
out of 2,821
66th
Division
Manufacturing
579
out of 1,551
63rd
Major group
Chemicals And Allied Products
398
out of 877
55th
Industry group
Drugs
387
out of 840
54th
Industry
Biological Products, Except Diagnostic Substances
120
out of 204
41st
Source: SEC filing on April 24, 2024.

Yurasov's colleagues

We found three more compensation records of executives who worked with Sergey Yurasov at Black Diamond Therapeutics in 2023.

2023

Mark Velleca

Black Diamond Therapeutics

Chief Executive Officer

2023

David Epstein

Black Diamond Therapeutics

Chief Executive Officer

2023

Fang Ni

Black Diamond Therapeutics

Chief Financial Officer

News

You may also like